An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration
Schema therapy is effective for treating severe depression
Proteins such as tumour markers can be easily and sensitively detected by their scattered light
Schema therapy is effective for treating severe depression
In 2015, around 4.5 million people died prematurely from diseases attributed to ambient air pollution, including 237,000 children under the age of five from respiratory infections. This is the result of a study published by the Max Planck Institute for Chemistry in Mainz and the London School of Hygiene & Tropical Medicine.
Schema therapy is effective for treating severe depression
165 new cancer genes identified with the help of machine learning
Schema therapy is effective for treating severe depression
Viola Priesemann from the Max Planck Institute for Dynamics and Self-Organization talks about the spread of the coronavirus Sars-CoV-2 and strategies to contain the Covid-19 epidemic. She is one of the authors of a statement by non-university research organisations on pandemic.
Schema therapy is effective for treating severe depression
The human geneticist Stefan Mundlos warns against intervention in the human germline made possible by the CRISPR/Cas ‘gene scissors’.
Schema therapy is effective for treating severe depression
The human geneticist Stefan Mundlos warns against intervention in the human germline made possible by the CRISPR/Cas ‘gene scissors’.
Schema therapy is effective for treating severe depression
Molecular barriers prevent pancreatic cells from losing their identity
Schema therapy is effective for treating severe depression
Max Planck researchers and their collaborators reveal transformation of colon organoids in vitro
Schema therapy is effective for treating severe depression
An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration
Schema therapy is effective for treating severe depression
